We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for lumacaftor/ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
lumacaftor/ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Granules and tablets in fixed dose combinations
Indication
For the treatment of Cystic fibrosis
Therapeutic area
Respiratory